LIMN · Categories · 8-K
LIMN - SEC Form 8-K filings
Liminatus Pharma Inc. (LIMN) sec form 8-k filings - real-time wire coverage filtered to 8-K only.
Recent 8-K for LIMN
- Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
- Amendment: Liminatus Pharma Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Leadership Update, Unregistered Sales of Equity Securities, Changes in Registrant's Certifying Accountant8-K/A - Liminatus Pharma, Inc. (0001971387) (Filer)
- Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Unregistered Sales of Equity Securities, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status, Regulation FD Disclosure, Other8-K - Liminatus Pharma, Inc. (0001971387) (Filer)